Showing results (1-10 of 201) with videos related to
Sort By:
Pageof 21
Pharmacogenomics and Personalized Medicine|August 25, 2021
The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung CancerAlice Mogenet, Laurent Greillier, Pascale TomasiniBulletin Du Cancer|March 28, 2025
[Recommendations for the management of oligometatic NSCLC]Alice Mogenet, Laurent Greillier, Pascale TomasiniBulletin Du Cancer|September 26, 2020
[Predictable toxicities with futures immunotherapies or combinations]Alice Mogenet, Pascale Tomasini, Laurent Greillier, et al.Clinical & Experimental Metastasis|December 20, 2023
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastasesSébastien Benzekry, Pirmin Schlicke, Alice Mogenet, et al.Expert Opinion on Investigational Drugs|August 3, 2026
Budigalimab: a viable option for patients with advanced solid tumorsAlice Mogenet, Laurent GreillierTherapeutic Advances in Respiratory Disease|June 25, 2016
Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experienceLaurent Greillier, Pascale Tomasini, Fabrice BarlesiExpert Opinion on Biological Therapy|June 9, 2015
Necitumumab for non-small cell lung cancerLaurent Greillier, Pascale Tomasini, Fabrice BarlesiTranslational Lung Cancer Research|December 4, 2018
The clinical utility of tumor mutational burden in non-small cell lung cancerLaurent Greillier, Pascale Tomasini, Fabrice BarlesiExpert Review of Anticancer Therapy|July 14, 2022
Nivolumab plus ipilimumab in malignant pleural mesotheliomaCamille Travert, Pascale Tomasini, Laurent GreillierEuropean Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Personalised medicine for nonsmall cell lung cancerCéline Mascaux, Pascale Tomasini, Laurent Greillier, et al.Pageof 21